Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-033249
Filing Date
2021-05-17
Accepted
2021-05-17 17:56:51
Documents
2
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1522
2 EX-24 DOCUMENT attachment1.htm EX-24 3263
  Complete submission text file 0001209191-21-033249.txt   6132
Mailing Address 3621 SOUTH STATE ST 695 KMS PL ANN ARBOR MI 48108
Business Address
MAYLEBEN TIMOTHY M (Reporting) CIK: 0001242613 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39971 | Film No.: 21932891

Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations